{"id":"https://openalex.org/W2004011845","doi":"https://doi.org/10.1016/j.diabres.2009.08.009","title":"Dual onset of type 1 diabetes mellitus and Graves\u2019 disease during treatment with pegylated interferon \u03b1-2b and ribavirin for chronic hepatitis C","display_name":"Dual onset of type 1 diabetes mellitus and Graves\u2019 disease during treatment with pegylated interferon \u03b1-2b and ribavirin for chronic hepatitis C","publication_year":2009,"publication_date":"2009-09-10","ids":{"openalex":"https://openalex.org/W2004011845","doi":"https://doi.org/10.1016/j.diabres.2009.08.009","mag":"2004011845","pmid":"https://pubmed.ncbi.nlm.nih.gov/19744739"},"language":"en","primary_location":{"id":"doi:10.1016/j.diabres.2009.08.009","doi":"https://doi.org/10.1016/j.diabres.2009.08.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.diabres.2009.08.009","pdf_url":null,"source":{"id":"https://openalex.org/S171311646","display_name":"Diabetes Research and Clinical Practice","issn_l":"0168-8227","issn":["0168-8227","1872-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Research and Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016279116","display_name":"Masayuki Hayashi","orcid":"https://orcid.org/0000-0002-7461-1723","observed_orcids":["https://orcid.org/0000-0002-7461-1723"]},"institutions":[{"id":"https://openalex.org/I4210146922","display_name":"Chukyo Hospital","ror":"https://ror.org/03j56s085","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210146922"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masayuki Hayashi","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Chukyo Hospital, Nagoya 457-8510, Japan. masayuki_hayashi@chukyo-hosp.jp","Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Chukyo Hospital, Nagoya 457-8510, Japan. masayuki_hayashi@chukyo-hosp.jp","institution_ids":["https://openalex.org/I4210146922"]},{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan","institution_ids":["https://openalex.org/I4210146922"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yuko Kataoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146922","display_name":"Chukyo Hospital","ror":"https://ror.org/03j56s085","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210146922"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Kataoka","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan","institution_ids":["https://openalex.org/I4210146922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084194598","display_name":"Kazushige Tachikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146922","display_name":"Chukyo Hospital","ror":"https://ror.org/03j56s085","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210146922"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazushige Tachikawa","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan","institution_ids":["https://openalex.org/I4210146922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035150270","display_name":"Hiroki Koguchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146922","display_name":"Chukyo Hospital","ror":"https://ror.org/03j56s085","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210146922"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroki Koguchi","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Chukyo Hospital, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Chukyo Hospital, Nagoya, Japan","institution_ids":["https://openalex.org/I4210146922"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049974598","display_name":"Hiroshi L. TANAKA","orcid":"https://orcid.org/0000-0002-3661-9310","observed_orcids":["https://orcid.org/0000-0002-3661-9310"]},"institutions":[{"id":"https://openalex.org/I4210146922","display_name":"Chukyo Hospital","ror":"https://ror.org/03j56s085","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210146922"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Tanaka","raw_affiliation_strings":["Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, Chukyo Hospital, 1-1-10 Sanjo, Minami-ku, Nagoya 457-8510, Japan","institution_ids":["https://openalex.org/I4210146922"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5016279116"],"corresponding_institution_ids":["https://openalex.org/I4210146922"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":0.5936,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.65997754,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"86","issue":"2","first_page":"e19","last_page":"e21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.32010000944137573,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/graves-disease","display_name":"Graves' disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.824999988079071},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha-2b","display_name":"pegylated interferon alpha-2b","score":0.9660000205039978},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-induced-autoimmunity","display_name":"drug-induced autoimmunity","score":0.6690000295639038},{"id":"https://openalex.org/keywords/ketoacidosis","display_name":"ketoacidosis","score":0.8709999918937683},{"id":"https://openalex.org/keywords/autoimmune-thyroid-disease","display_name":"autoimmune thyroid disease","score":0.5329999923706055},{"id":"https://openalex.org/keywords/antiviral-therapy-adverse-effects","display_name":"antiviral therapy adverse effects","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.952876091003418},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.9527757167816162},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.8133268356323242},{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.6265625357627869},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4789772033691406},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.4670129418373108},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.41251373291015625},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3978874683380127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3973022699356079},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.39111292362213135},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37547653913497925},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.26454663276672363},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1773172914981842},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1616876721382141}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006111","descriptor_name":"Graves Disease","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006111","descriptor_name":"Graves Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.diabres.2009.08.009","doi":"https://doi.org/10.1016/j.diabres.2009.08.009","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.diabres.2009.08.009","pdf_url":null,"source":{"id":"https://openalex.org/S171311646","display_name":"Diabetes Research and Clinical Practice","issn_l":"0168-8227","issn":["0168-8227","1872-8227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Research and Clinical Practice","raw_type":"journal-article"},{"id":"pmid:19744739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19744739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes research and clinical practice","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W36135425","https://openalex.org/W1978859946","https://openalex.org/W1984004040","https://openalex.org/W1984044364","https://openalex.org/W1986032822","https://openalex.org/W2003626573","https://openalex.org/W2036511637","https://openalex.org/W2053274278","https://openalex.org/W2064870615","https://openalex.org/W2100881596","https://openalex.org/W2110343070","https://openalex.org/W2162058293"],"related_works":["https://openalex.org/W2064434283","https://openalex.org/W1977783864","https://openalex.org/W2104907626","https://openalex.org/W1985740652","https://openalex.org/W1985137158","https://openalex.org/W1984004040","https://openalex.org/W2140152677","https://openalex.org/W2419382124","https://openalex.org/W2366365710","https://openalex.org/W2034304810"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}